"We enjoy the advantage of having a large amount of clinical data on 2,000 patients. So we analyzed who received which cells and which cells worked best in different conditions. This allowed us to create our selection process through molecular profiling,” explained Medistem (Panama) Founder and CEO Dr. Neil Riordan. Operating what is arguably the [...]
An article published this month in Thieme Journal of Knee Surgery entitled, "The Use of Biologic Agents in Athletes with Knee Injuries" concluded that "Biologic agents... are becoming the mainstay of nonoperative therapy in the high-demand athletic population." but "...Unfortunately, strict regulations by the FDA continue to restrict their application in clinical practice." The good [...]
Wise County Messenger By Bob Buckel | Published Wednesday, July 31, 2013 A middle-aged man named Neil got his knee “scoped” in a Decatur operating room recently. That’s not unusual. Wise Regional Health System’s OR is a busy place, and arthroscopic knee surgery is a common procedure. But this particular knee had an interesting twist. [...]
Researchers at Duke University announced a promising new stem cell therapy aimed at osteoarthritis prevention after a joint injury. The probability of developing arthritis after injury (post-traumatic arthritis - PTA) greatly increases after injury. Currently, the US FDA has not approved any drugs that slow or eliminate the progression of PTA. However, at Duke researchers [...]
Intravenously administered adipose-derived stem cells will tend to migrate back to the fresh wound site if it is not given an adequate time to heal. Therefore, it is essential to allow about one week after the mini-liposuction before administering any stem cells intravenously. Otherwise, there is a likelihood that the treatment will not be as [...]
Once again, the adult stem cell therapy pioneered by the veterinary company Vet-Stem comes to the rescue of man's best friend.
The adult stem cell product Prochymal, developed by Osiris Therapeutics, is now being used in the treatment of type I diabetes.
A group of veterinarians at Cornell University has conducted a controlled study in which autologous adult stem cells were evaluated in the treatment of tendon injuries in horses.
Osiris Begins Phase II Clinical Trial With Adult Stem Cell Therapy for the Treatment of Heart Attack
Osiris Therapeutics begins Phase II clinical trials for its Prochymal adult stem cell therapy in the regeneration of cardiac tissue following myocardial infarction.
Once again, intrepid four-legged patients are blazing new trails in adult stem cell therapy.